Mats Bengtsson
Overview
Explore the profile of Mats Bengtsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
587
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Petersdorf E, Bengtsson M, De Santis D, Dubois V, Fleischhauer K, Gooley T, et al.
J Clin Oncol
. 2020 Jun;
38(24):2712-2718.
PMID: 32479188
Purpose: The main aim of this study was to evaluate the significance of HLA-DPB1 expression in acute graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HCT) from HLA-A, -B, -C, -DRB1,...
12.
Hurley C, Kempenich J, Wadsworth K, Sauter J, Hofmann J, Schefzyk D, et al.
HLA
. 2020 Jan;
95(6):516-531.
PMID: 31970929
A catalog of common, intermediate and well-documented (CIWD) HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQB1 and -DPB1 alleles has been compiled from over 8 million individuals using data from...
13.
Bruggemann A, Mallmin H, Bengtsson M, Hailer N
J Bone Joint Surg Am
. 2020 Jan;
102(5):368-374.
PMID: 31895169
Background: Tantalum implants have been used in >500,000 orthopaedic patients. Although the risks of metallosis and aseptic lymphocyte-dominated vasculitis-associated lesions (ALVAL) after total hip arthroplasty (THA) are being debated, we...
14.
Petersdorf E, Carrington M, OhUigin C, Bengtsson M, De Santis D, Dubois V, et al.
Lancet Haematol
. 2019 Nov;
7(1):e50-e60.
PMID: 31669248
Background: The success of unrelated haemopoietic cell transplantation (HCT) is limited by graft-versus-host disease (GVHD), which is the main post-transplantation challenge when HLA-matched donors are unavailable. A sequence dimorphism in...
15.
Sorman A, Knutson C, Bengtsson M
HLA
. 2019 Feb;
93(6):485-486.
PMID: 30773829
HLA-B*08:181 differs from HLA-B*08:01:01:01 in codon 94, 95, 97 and 99 of exon 3.
16.
Osoegawa K, Vayntrub T, Wenda S, De Santis D, Barsakis K, Ivanova M, et al.
Hum Immunol
. 2019 Feb;
80(4):228-236.
PMID: 30738112
The 17th International HLA and Immunogenetics Workshop (IHIW) organizers conducted a Pilot Study (PS) in which 13 laboratories (15 groups) participated to assess the performance of the various sequencing library...
17.
Hedin A, Knutson C, Bengtsson M
HLA
. 2019 Jan;
93(4):223-224.
PMID: 30697973
HLA-B*15:465 differs from HLA-B*15:01:01:01 in codon 336 of exon 7.
18.
Lorant T, Bengtsson M, Eich T, Eriksson B, Winstedt L, Jarnum S, et al.
Am J Transplant
. 2018 Mar;
18(11):2752-2762.
PMID: 29561066
Safety, immunogenicity, pharmacokinetics, and efficacy of the IgG-degrading enzyme of Streptococcus pyogenes (IdeS [imlifidase]) were assessed in a single-center, open-label ascending-dose study in highly sensitized patients with chronic kidney disease....
19.
Jordan S, Lorant T, Choi J, Kjellman C, Winstedt L, Bengtsson M, et al.
N Engl J Med
. 2017 Aug;
377(5):442-453.
PMID: 28767349
Background: Donor-specific antibodies create an immunologic barrier to transplantation. Current therapies to modify donor-specific antibodies are limited and ineffective in the most highly HLA-sensitized patients. The IgG-degrading enzyme derived from...
20.
Wadelius M, Eriksson N, Kreutz R, Bondon-Guitton E, Ibanez L, Carvajal A, et al.
Clin Pharmacol Ther
. 2017 Aug;
103(5):843-853.
PMID: 28762467
Agranulocytosis is a serious, although rare, adverse reaction to sulfasalazine, which is used to treat inflammatory joint and bowel disease. We performed a genome-wide association study comprising 9,380,034 polymorphisms and...